The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
4D MOLECULAR THERAPEUTICS IN COM 35104E100 33,128 1,509,944 SH   SOLE   1,509,944 0 0
AMRYT PHARMA PLC SPONSORED ADS 03217L106 17,712 1,640,000 SH   SOLE   1,640,000 0 0
ARGENX SE SPONSORED ADR 04016X101 7,774 22,200 SH   SOLE   22,200 0 0
ARROWHEAD PHARMACEUTICALS IN COM 04280A100 46,438 700,426 SH   SOLE   700,426 0 0
ARVINAS INC COM 04335A105 46,282 563,451 SH   SOLE   563,451 0 0
BLUEPRINT MEDICINES CORP COM 09627Y109 69,144 645,539 SH   SOLE   645,539 0 0
GENMAB A/S SPONSORED ADS 372303206 5,044 127,500 SH   SOLE   127,500 0 0
MAGENTA THERAPEUTICS INC COM 55910K108 13,977 3,155,082 SH   SOLE   3,155,082 0 0
MERUS N V COM N5749R100 28,509 896,502 SH   SOLE   896,502 0 0
PIERIS PHARMACEUTICALS INC COM 720795103 12,083 3,196,527 SH   SOLE   3,196,527 0 0
REGENXBIO INC COM 75901B107 33,145 1,013,596 SH   SOLE   1,013,596 0 0
SPDR S&P 500 ETF TR TR UNIT 78462F103 474,960 1,000,000 SH Put SOLE   0 0 1,000,000
SPERO THERAPEUTICS INC COM 84833T103 79,477 4,964,181 SH   SOLE   4,964,181 0 0
UNIQURE NV SHS N90064101 14,025 676,206 SH   SOLE   676,206 0 0